Clinical Trial Update: Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy

View source ↗

Summary

Updates results from a trial evaluating quality of life and safety when postmenopausal breast cancer patients switch from tamoxifen to aromatase inhibitor thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Exemestane (Exemestane)
• Letrozole (letrozole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Pfizer | Conditions: Breast Neoplasms | Status: COMPLETED